GO:0016779 nucleotidyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016779 nucleotidyltransferase activity is a molecular function defined as the catalysis of the transfer of a nucleotidyl group from one compound (donor) to another (acceptor).
• cGAS is a well-characterized nucleotidyltransferase that synthesizes cyclic GMP-AMP (cGAMP) from ATP and GTP upon binding to cytosolic DNA, activating the STING-dependent type I interferon pathway.
• Nucleotidyltransferase activity is tightly regulated by substrate availability, post-translational modifications, and liquid phase condensation, which enhances cGAS enzymatic activity.
• Dysregulation of nucleotidyltransferase-dependent pathways, particularly cGAS-STING, contributes to cancer, inflammatory diseases, and neurodegenerative conditions.
• CRISPR-based models, including knockout, point mutation, and knock-in, are essential for dissecting the causal roles of nucleotidyltransferase genes in disease.
• EDITGENE provides comprehensive CRISPR services, including library screening and bioinformatics, to accelerate research on nucleotidyltransferase activity.
Description
Nucleotidyltransferase activity (GO:0016779) is a fundamental molecular function that catalyzes the transfer of a nucleotidyl group from a donor molecule to an acceptor molecule. This activity is essential for diverse biological processes, including nucleic acid synthesis, signal transduction, and immune defense. A prominent example is cyclic GMP-AMP synthase (cGAS), which functions as a cytosolic DNA sensor and synthesizes the second messenger cGAMP, thereby activating the STING pathway and type I interferon responses. Understanding the mechanisms and regulation of nucleotidyltransferases is critical for elucidating their roles in health and disease. Recent studies have highlighted the importance of cGAS-STING signaling in tumor suppression, inflammation, and pathogen clearance. Moreover, the enzymatic activity of cGAS is regulated by liquid phase condensation, which promotes its activation upon DNA binding. These findings underscore the need for precise experimental models to study nucleotidyltransferase function. This article provides a comprehensive overview of GO:0016779, covering its definition, key genes, regulatory mechanisms, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional interrogation.
nucleotidyltransferase activity At A Glance
| GO ID | GO:0016779 |
|---|---|
| GO term | nucleotidyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of nucleotidyl group transfer from donor to acceptor |
| Example enzyme | cGAS (cyclic GMP-AMP synthase) |
| Key pathway | cGAS-STING innate immune signaling |
| Substrate | ATP, GTP (for cGAS) |
| Product | cGAMP (cyclic GMP-AMP) |
What Is GO:0016779?
According to the Gene Ontology, nucleotidyltransferase activity (GO:0016779) is defined as the catalysis of the transfer of a nucleotidyl group from one compound (donor) to another (acceptor). This activity encompasses enzymes that add nucleotide moieties to substrates, often as part of nucleic acid metabolism or signaling. The definition emphasizes the transfer reaction, which is central to the function of enzymes like cGAS, which transfers nucleotides to form cyclic dinucleotides.
Why Is nucleotidyltransferase activity Important in Cell Biology?
Nucleotidyltransferase activity is crucial for a wide range of biological processes, from nucleic acid synthesis to immune signaling. The cGAS enzyme, a nucleotidyltransferase, plays a central role in detecting cytosolic DNA and initiating innate immune responses. This pathway is implicated in host defense against pathogens, autoimmune diseases, and cancer. Understanding the regulation of nucleotidyltransferase activity can reveal therapeutic targets for modulating immune responses and treating related disorders.
• cGAS is a nucleotidyltransferase that synthesizes cGAMP, a second messenger activating STING and type I interferon.
• The cGAS-STING pathway is essential for sensing cytosolic DNA from pathogens or damaged cells.
• Nucleotidyltransferase activity is involved in tumor suppression through p53-mediated engagement of cGAS/STING.
• Dysregulation of cGAS-STING signaling contributes to inflammatory diseases such as acute liver injury.
• Mitochondrial DNA release activates cGAS-STING, linking nucleotidyltransferase activity to neuroinflammation.
• Liquid phase condensation regulates cGAS activity, highlighting biophysical control of nucleotidyltransferases.
• STING autoinhibition and activation mechanisms are critical for pathway fidelity.
• Nucleotidyltransferase activity is a potential target for anti-inflammatory and anticancer therapies.
• CRISPR screening can identify novel regulators of nucleotidyltransferase pathways.
• Understanding nucleotidyltransferase function aids in developing vaccines and immunotherapies.
Molecular Mechanism of nucleotidyltransferase activity
Substrate Binding and Activation
In simple terms: The enzyme grabs its building blocks and gets ready to work.
Nucleotidyltransferases such as cGAS bind to their substrates, ATP and GTP, in a sequential manner. Upon binding to cytosolic DNA, cGAS undergoes conformational changes that align the substrates for catalysis, leading to the synthesis of cGAMP. This activation is essential for downstream signaling.
Catalytic Transfer of Nucleotidyl Group
In simple terms: The enzyme links the building blocks together to form a signal molecule.
The catalytic mechanism involves the transfer of a nucleotidyl group from ATP to GTP, forming a cyclic dinucleotide, cGAMP. This reaction is mediated by conserved residues in the active site of cGAS. The product cGAMP then acts as a second messenger to activate STING.
Liquid Phase Condensation
In simple terms: The enzyme forms droplets to enhance its activity.
DNA-induced liquid phase condensation of cGAS concentrates the enzyme and its substrates, thereby enhancing enzymatic activity and promoting robust immune signaling. This biophysical mechanism ensures efficient cGAMP production.
Regulation by Post-Translational Modifications
In simple terms: Chemical tags can turn the enzyme on or off.
Post-translational modifications, such as phosphorylation and ubiquitination, regulate cGAS activity and stability. For instance, STING autoinhibition and activation are controlled by conformational changes and interactions with other proteins. These regulatory layers prevent aberrant immune activation.
Downstream Signaling and Feedback
In simple terms: The signal triggers a cascade that can loop back.
cGAMP binds to STING, triggering its activation and downstream signaling through TBK1 and IRF3, leading to type I interferon production. This pathway is subject to feedback regulation to avoid excessive inflammation.
Key Genes Involved in GO:0016779 nucleotidyltransferase activity
The following genes encode proteins with nucleotidyltransferase activity or are key components of related signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CGAS | Cyclic GMP-AMP synthase; synthesizes cGAMP from ATP and GTP | Central to cytosolic DNA sensing and innate immunity |
| STING1 | Adaptor protein that binds cGAMP and activates IRF3 | Mediates type I interferon response |
| TBK1 | Kinase that phosphorylates IRF3 downstream of STING | Essential for interferon signaling |
| IRF3 | Transcription factor that induces type I interferon genes | Key effector of antiviral response |
| NFKB1 | Transcription factor involved in inflammatory responses | Contributes to cGAS-STING-mediated inflammation |
| TFEB | Transcription factor regulating lysosome biogenesis | Activated by cGAS-STING to promote pathogen clearance |
| NLRP3 | Inflammasome sensor activated by mtDNA-cGAS-STING | Links nucleotidyltransferase activity to pyroptosis |
| XBP1 | Transcription factor in unfolded protein response | Deficiency impairs mitophagy and activates mtDNA-cGAS-STING |
| TP53 | Tumor suppressor that engages cGAS/STING | Connects nucleotidyltransferase activity to tumor suppression |
| VDAC1 | Mitochondrial channel for oxidized DNA exit | Facilitates mtDNA release to activate cGAS |
| MPTP | Mitochondrial permeability transition pore | Mediates mtDNA release for cGAS activation |
| ATG5 | Autophagy-related protein | Influences mitophagy and mtDNA-cGAS-STING |
| PINK1 | Mitophagy regulator | Affects mitochondrial DNA release |
| PRKN | Parkin, E3 ubiquitin ligase in mitophagy | Modulates mtDNA-cGAS-STING |
| OPTN | Autophagy receptor | Involved in mitophagy and immune regulation |
| SQSTM1 | p62, autophagy receptor | Regulates mitophagy and cGAS-STING |
| CALCOCO2 | NDP52, autophagy receptor | Participates in selective autophagy |
How Is nucleotidyltransferase activity Regulated?
Nucleotidyltransferase activity, particularly that of cGAS, is regulated at multiple levels. DNA binding induces conformational changes and liquid phase condensation, enhancing enzymatic activity. Post-translational modifications, including phosphorylation and ubiquitination, modulate cGAS stability and function. Additionally, the cGAS-STING pathway is subject to feedback inhibition to prevent excessive inflammation. Mitochondrial DNA release, regulated by mPTP and VDAC, provides ligands for cGAS activation. Autophagy and mitophagy pathways, involving XBP1, also influence cGAS-STING signaling by controlling mtDNA availability.
nucleotidyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CGAS | Cancer, autoimmunity, infection | Knockout mice, point mutation knock-in |
| STING1 | STING-associated vasculopathy | Knock-in of gain-of-function mutations |
| NLRP3 | Inflammatory diseases | Knockout and overexpression models |
| TP53 | Cancer | Knockout and point mutation models |
| XBP1 | Liver injury, metabolic disease | Conditional knockout mice |
Cancer
The cGAS-STING pathway, driven by nucleotidyltransferase activity, plays a critical role in tumor suppression. p53 engages cGAS/STING to promote antitumor immunity. Dysregulation of this pathway can lead to immune evasion and cancer progression. Targeting nucleotidyltransferase activity is a promising strategy for cancer immunotherapy.
Inflammatory and Autoimmune Diseases
Aberrant activation of cGAS-STING signaling contributes to chronic inflammation and autoimmune diseases. For example, mtDNA-cGAS-STING axis activation in macrophages promotes pyroptosis during acute liver injury. Similarly, sevoflurane-induced postoperative cognitive dysfunction involves mtDNA-cGAS-STING-dependent NLRP3 inflammasome activation. Modulating nucleotidyltransferase activity could mitigate these conditions.
Neurodegeneration
Neuroinflammation driven by cGAS-STING is implicated in neurodegenerative diseases. Mitochondrial dysfunction and mtDNA release activate cGAS, leading to inflammatory responses in the brain. Understanding nucleotidyltransferase regulation may offer therapeutic avenues for neuroprotection.
Infectious Diseases
Nucleotidyltransferase activity is essential for host defense against pathogens. cGAS detects cytosolic DNA from viruses and bacteria, initiating interferon responses. The cGAS-STING pathway also activates TFEB to stimulate lysosome biogenesis and pathogen clearance. Enhancing this activity could bolster antimicrobial immunity.
From nucleotidyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does cGAS nucleotidyltransferase activity require DNA binding? | Point mutation of DNA-binding residues |
| What is the role of cGAS in tumor suppression? | CGAS knockout mice |
| How does cGAMP binding activate STING? | STING knock-in with tagged versions |
| Can overexpression of cGAS enhance antiviral immunity? | CGAS overexpression cell lines |
| What are the downstream effectors of cGAS-STING? | Knockout of TBK1, IRF3 |
| Does liquid phase condensation regulate cGAS activity? | Knock-in of condensation-deficient mutants |
How to Study the nucleotidyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro enzymatic assay | cGAMP synthesis | Enzyme kinetics and inhibitor testing |
| ISRE-luciferase reporter | Type I interferon activation | High-throughput screening |
| Fluorescence microscopy | Liquid phase condensation | Visualizing cGAS activation |
| CRISPR knockout screen | Gene essentiality for pathway | Identifying novel regulators |
| Western blot | Protein expression and phosphorylation | Validating signaling changes |
| qRT-PCR | Interferon-stimulated gene expression | Quantifying immune response |
| Co-immunoprecipitation | Protein-protein interactions | Mapping signaling complexes |
Biochemical Assays for Nucleotidyltransferase Activity
In vitro enzymatic assays using recombinant cGAS and radiolabeled substrates can measure nucleotidyltransferase activity. These assays monitor the conversion of ATP and GTP to cGAMP, often using thin-layer chromatography or mass spectrometry.
Cell-Based Reporter Systems
Luciferase reporters driven by interferon-stimulated response elements (ISRE) are used to measure cGAS-STING pathway activation in cells. This method allows high-throughput screening of modulators.
Imaging of Liquid Phase Condensation
Fluorescence microscopy and live-cell imaging can visualize DNA-induced liquid phase condensation of cGAS. This technique reveals the spatiotemporal dynamics of enzyme activation.
CRISPR Screening for Pathway Regulators
Genome-wide CRISPR knockout screens can identify novel genes regulating cGAS-STING signaling. Such screens have uncovered components of the pathway and potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0016779 nucleotidyltransferase activity
Knockout
CRISPR knockout of CGAS or STING1 completely abolishes nucleotidyltransferase-mediated signaling, providing a clean background to study pathway components. Knockout models are essential for confirming the role of cGAS in DNA sensing and tumor suppression.
Point Mutation
Introducing point mutations in the catalytic domain of cGAS (e.g., D307A) can abrogate enzymatic activity without affecting DNA binding. Such models help dissect the specific contribution of nucleotidyltransferase activity to immune responses.
Knock-in
Knock-in of tagged cGAS (e.g., GFP or HA) allows for real-time tracking of protein localization and interactions. Knock-in of disease-associated STING mutations can model autoinflammatory conditions.
Overexpression
Overexpression of cGAS or STING in cell lines can amplify pathway activation, facilitating biochemical studies and drug screening. However, overexpression may cause artifacts, so results should be validated with endogenous models.
How EDITGENE Supports nucleotidyltransferase activity Research
Researchers studying nucleotidyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in immune signaling, inflammation, or cancer. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic interrogation of these pathways.
Contact EDITGENE today to design your custom CRISPR model for nucleotidyltransferase activity research.
Frequently Asked Questions About nucleotidyltransferase activity
What is nucleotidyltransferase activity?
Nucleotidyltransferase activity (GO:0016779) is the catalysis of the transfer of a nucleotidyl group from a donor to an acceptor molecule.
What genes are involved in nucleotidyltransferase activity?
Key genes include CGAS, STING1, TBK1, and IRF3, which are central to the cGAS-STING DNA sensing pathway.
How is nucleotidyltransferase activity regulated?
It is regulated by DNA binding, liquid phase condensation, post-translational modifications, and feedback inhibition.
What diseases are associated with nucleotidyltransferase activity?
Dysregulation is linked to cancer, autoimmune diseases, neurodegeneration, and infectious diseases.
What is the role of cGAS in immunity?
cGAS synthesizes cGAMP upon binding cytosolic DNA, activating STING and type I interferon responses.
How can I study nucleotidyltransferase activity in the lab?
Common methods include in vitro enzymatic assays, reporter systems, imaging, and CRISPR screens.
What CRISPR models are available for nucleotidyltransferase research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like CGAS and STING1.
Can nucleotidyltransferase activity be targeted therapeutically?
Yes, inhibitors of cGAS-STING are being explored for inflammatory diseases and cancer immunotherapy.
What is the connection between nucleotidyltransferase and autophagy?
Mitophagy regulates mtDNA release, which activates cGAS-STING, linking autophagy to nucleotidyltransferase signaling.
How does EDITGENE support nucleotidyltransferase research?
EDITGENE provides CRISPR knockout, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
Nucleotidyltransferase activity (GO:0016779) is a critical molecular function with profound implications for immune signaling, disease, and therapeutic development. The cGAS-STING pathway serves as a paradigm for understanding how nucleotidyltransferases detect danger signals and orchestrate immune responses. Continued research using advanced CRISPR models will unravel the complexities of this activity and pave the way for novel treatments.
References
- 1. Sun L et al.. 2013. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.. Science 339(6121):786-91 PMID: 23258413
- 2. Xu Y et al.. 2025. The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance.. Immunity 58(2):309-325.e6 PMID: 39689715
- 3. Xian H et al.. 2022. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling.. Immunity 55(8):1370-1385.e8 PMID: 35835107
- 4. Ghosh M et al.. 2023. p53 engages the cGAS/STING cytosolic DNA sensing pathway for tumor suppression.. Mol Cell 83(2):266-280.e6 PMID: 36638783
- 5. Du M et al.. 2018. DNA-induced liquid phase condensation of cGAS activates innate immune signaling.. Science 361(6403):704-709 PMID: 29976794
- 6. Yang NS et al.. 2024. mtDNA-cGAS-STING axis-dependent NLRP3 inflammasome activation contributes to postoperative cognitive dysfunction induced by sevoflurane in mice.. Int J Biol Sci 20(5):1927-1946 PMID: 38481801
- 7. Liu Z et al.. 2022. XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury.. Redox Biol 52:102305 PMID: 35367811
- 8. Liu S et al.. 2023. The mechanism of STING autoinhibition and activation.. Mol Cell 83(9):1502-1518.e10 PMID: 37086726
